Literature DB >> 6210622

Antibody mediated delivery of toxic molecules to antigen bearing target cells.

V Raso.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6210622     DOI： 10.1111/j.1600-065x.1982.tb00391.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  11 in total

1.  Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

Authors:  E S Vitetta; W Cushley; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 2.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 3.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.

Authors:  K S Webb; S N Liberman; J L Ware; P J Walther
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells.

Authors:  C K Tebbi; D Chervinsky; B K Seon
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

6.  The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.

Authors:  C F Scott; V S Goldmacher; J M Lambert; R V Chari; S Bolender; M N Gauthier; W A Blättler
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

Authors:  J R Corvalan; W Smith; V A Gore; D R Brandon
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.

Authors:  R H Begent; J A Ledermann; A J Green; K D Bagshawe; S J Riggs; F Searle; P A Keep; T Adam; R G Dale; M G Glaser
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

9.  Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.

Authors:  E S Vitetta; R J Fulton; J W Uhr
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

10.  Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A.

Authors:  J A Ledermann; R H Begent; K D Bagshawe; S J Riggs; F Searle; M G Glaser; A J Green; R G Dale
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.